- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06880783
Manual Diaphragmatic Release Technique on Exercise Capacity and Sleep Quality (DM and sleep)
April 11, 2025 updated by: Mohammed Youssef Elhamrawy, Beni-Suef University
Effect of Manual Diaphragmatic Release Technique on Exercise Capacity and Sleep Quality in Older Adults With Type II Diabetes: a Randomized Controlled Trial
To investigate if there is a significant effect of manual diaphragmatic release technique on exercise capacity, sleep quality, chest expansion, ADL, fatigue and quality of life in older adults with type II diabetes.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Participants, including both genders, will have a history of Diabetes Type II for more than one year.
They will be well controlled with HbA1c≤7.
Patients will be aged from 55 years and above and had a body mass index less than 30 kg/m².
Patients will follow up on the training program and instructions.
They will be medically stable.
Study Type
Interventional
Enrollment (Estimated)
44
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Mohammed Yo Elhamrawy, Ph.D
- Phone Number: +201282805567
- Email: dr_melhamrawy@yahoo.com
Study Locations
-
-
-
Banī Suwayf, Egypt, 62511
- Recruiting
- Beni suef hospital
-
Contact:
- Mohammed YO Elhamrawy, PHD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- History of Diabetes Type II for more than one year.
- They will be well controlled with HbA1c≤7.
- Patients will be aged from 55 years and above and had a body mass index less than 30 kg/m².
- Patients will follow up on the training program and instructions. They will be medically stable.
Exclusion Criteria:
- Chest diseases.
- Diaphragmatic hernia, clinical evidence of phrenic nerve injury, recent abdominal or thoracic surgery, or history of traumatic lesion possibly affecting diaphragm.
- History of Myocardial infarction and/or cardiothoracic surgery
- Unstable medical status.
- Cognitive disability hindering responding to the questionnaires.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Study Group
Participants will receive manual diaphragm release technique combined with deep breathing exercises
|
The participant should be supine with relaxed limbs, and the therapist should position themselves at the head, making manual contact with the pisiform, hypothenar region, and fingers.
The therapist should gently pull the contact towards the head, deepen it during exhalation, and gradually increase the depth.
Participants in a crook laying position are instructed to inhale through the nose, lift the abdomen, and let out through the mouth, breathing six breaths per minute for 30 minutes.
|
|
Active Comparator: Control group
Participants will receive deep breathing exercises
|
Participants in a crook laying position are instructed to inhale through the nose, lift the abdomen, and let out through the mouth, breathing six breaths per minute for 30 minutes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
6-minute walk test
Time Frame: up to 6 weeks
|
The 6 Minute Walk Test is a sub-maximal exercise test used to assess aerobic capacity and endurance.
The distance covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity.
|
up to 6 weeks
|
|
Pittsburgh Sleep Quality Index (PSQI)
Time Frame: up to 6 weeks
|
The Pittsburgh Sleep Quality Index (PSQI) is a self-report questionnaire that assesses sleep quality over a 1-month time interval.
The measure consists of 19 individual items, creating 7 components that produce one global score, and takes 5-10 minutes to complete
|
up to 6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 30, 2025
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
October 1, 2026
Study Registration Dates
First Submitted
March 12, 2025
First Submitted That Met QC Criteria
March 12, 2025
First Posted (Actual)
March 18, 2025
Study Record Updates
Last Update Posted (Actual)
April 15, 2025
Last Update Submitted That Met QC Criteria
April 11, 2025
Last Verified
March 1, 2025
More Information
Terms related to this study
Other Study ID Numbers
- Diabetes and Sleep Quality
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
University of Colorado, DenverMassachusetts General Hospital; Ann & Robert H Lurie Children's Hospital of... and other collaboratorsRecruitingDiabetes Mellitus | Diabetes | Type 2 Diabetes | Diabetes Mellitus Type 2 | Diabetes Mellitus, Type I | Diabetes Mellitus Type II | Diabetes Mellitus, Insulin-Dependent | Diabetes, Autoimmune | Type 1 Diabetes (T1D) | Diabetes Type 2 on Insulin | Diabetes, Type IIUnited States
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
University of North Carolina, Chapel HillAmerican Diabetes AssociationNot yet recruitingType 2 Diabetes Mellitus (T2DM) | Diabetes (DM) | Insulin Dependent Diabetes | Type 1 Diabetes (T1D) | Diabetes Education | Diabetes Care | Diabetes (Insulin-requiring, Type 1 or Type 2)United States
-
University of Trás-os-Montes and Alto DouroCompletedType 2 Diabetes Mellitus | Diabetes-Related ComplicationsPortugal
-
University of North Carolina, Chapel HillAmerican Heart AssociationRecruitingType 2 Diabetes | Nutrition | Diabetes Type 2 | T2DM (Type 2 Diabetes Mellitus) | Diabetes Mellitis | T2DM | Diabetes EducationUnited States
-
VeraLight, Inc.InLight SolutionsUnknownGestational Diabetes | Insulin Dependent Diabetes | Non Insulin Dependent DiabetesUnited States
-
Northern Care Alliance NHS Foundation TrustBrighter ABCompletedDiabetes type1 | Diabetes type2United Kingdom
-
COUR Pharmaceutical Development Company, Inc.RecruitingType 1 Diabetes | Type 1 Diabetes Mellitus | T1DM | T1D | Type 1 Diabetes in Adolescence | Type 1 Diabetes in Children | Type 1 Diabetes Patients | Type 1 Diabetes Mellitis | T1DM - Type 1 Diabetes Mellitus | Type 1 Diabetes (Juvenile Onset)United States
-
Garvan Institute of Medical ResearchWeizmann Institute of ScienceCompletedType 2 Diabetes Mellitus | Pre DiabetesAustralia
Clinical Trials on manual diaphragm release technique
-
Helga Cecília Muniz de SouzaUniversidade Federal de PernambucoCompleted
-
Daniella Cunha BrandaoCompleted
-
Universidade Federal de PernambucoCompleted
-
Tokat Gaziosmanpasa UniversityRecruitingDiaphragm; RelaxationTurkey
-
Beni-Suef UniversityActive, not recruitingRespiratory DiseaseEgypt
-
Karabuk UniversityRecruiting
-
Middle East UniversityNot yet recruitingLung Function | Rheumatic Arthritis
-
Cairo UniversityRecruitingDiabetes | ElderlyEgypt
-
Universidade Federal de PernambucoCompletedCopd | Diaphragmatic Disorder | Chest DisordersBrazil
-
Universidad de GranadaCompleted